Alessandro Bonifazi, Michael Ellenberger, Zachary J Farino, Despoina Aslanoglou, Rana Rais, Sandra Pereira, José O Mantilla-Rivas, Comfort A Boateng, Amy J Eshleman, Aaron Janowsky, Margaret K Hahn, Gary J Schwartz, Barbara S Slusher, Amy Hauck Newman, Zachary Freyberg
Dopamine (DA) D 2 -like receptors in both the central nervous system (CNS) and the periphery are key modulators of metabolism. Moreover, disruption of D 2 -like receptor signaling is implicated in dysglycemia. Yet, the respective metabolic contributions of CNS versus peripheral D 2 -like receptors including D 2 (D2R) and D 3 (D3R) receptors remain poorly understood. To address this, we developed new pharmacological tools, D 2 -like receptor agonists with diminished and delayed blood-brain barrier capability, to selectively manipulate D2R/D3R signaling in the periphery...
February 24, 2024: bioRxiv